GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » YSB Inc (HKSE:09885) » Definitions » Debt-to-Equity

YSB (HKSE:09885) Debt-to-Equity : 0.11 (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is YSB Debt-to-Equity?

YSB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was HK$105 Mil. YSB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was HK$126 Mil. YSB's Total Stockholders Equity for the quarter that ended in Jun. 2024 was HK$2,174 Mil. YSB's debt to equity for the quarter that ended in Jun. 2024 was 0.11.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for YSB's Debt-to-Equity or its related term are showing as below:

HKSE:09885' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.1   Med: 0.03   Max: 0.11
Current: 0.11

During the past 4 years, the highest Debt-to-Equity Ratio of YSB was 0.11. The lowest was -0.10. And the median was 0.03.

HKSE:09885's Debt-to-Equity is ranked better than
78.66% of 553 companies
in the Healthcare Providers & Services industry
Industry Median: 0.48 vs HKSE:09885: 0.11

YSB Debt-to-Equity Historical Data

The historical data trend for YSB's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YSB Debt-to-Equity Chart

YSB Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
-0.10 -0.06 -0.04 0.11

YSB Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Debt-to-Equity Get a 7-Day Free Trial N/A -0.04 0.10 0.11 0.11

Competitive Comparison of YSB's Debt-to-Equity

For the Pharmaceutical Retailers subindustry, YSB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

YSB's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, YSB's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where YSB's Debt-to-Equity falls into.


YSB Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

YSB's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(131.317 + 98.006) / 2099.795
=0.11

YSB's Debt to Equity Ratio for the quarter that ended in Jun. 2024 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(104.739 + 125.763) / 2174.45
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

YSB  (HKSE:09885) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

YSB Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of YSB's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

YSB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » YSB Inc (HKSE:09885) » Definitions » Debt-to-Equity
Comparable Companies
HKSE:03390 HKSE:01345 HKSE:01110 HKSE:02211 HKSE:06108 HKSE:00348 HKSE:00241 WBA BSP:RADL3 TSE:3088 SAU:4164 SHSE:603939 TSE:3349 SHSE:600998 TSE:3391 JSE:CLS TSE:3141 TSE:9989 TSE:7649 SAU:4163
Traded in Other Exchanges
N/A
Address
No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN
Website
https://www.ysbang.cn
YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream safely and efficiently, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. It has turned the process of pharmaceutical transaction and service into a digitalized, standardized and scalable one.
Executives
Chu Mang Yee 2201 Interest of corporation controlled by you
Meta Group Limited 2201 Interest of corporation controlled by you
Sounda Properties Limited 2201 Interest of corporation controlled by you
Shenzhen Songhe International Capital Management Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. 2101 Beneficial owner
Shanghai Fosun Pharmaceutical (group) Co., Ltd. 2201 Interest of corporation controlled by you
Shanghai Fosun High Technology (group) Co., Ltd. 2201 Interest of corporation controlled by you
Chen Xiaohong 2201 Interest of corporation controlled by you
H Capital V Gp, L.p. 2201 Interest of corporation controlled by you
H Capital V Gp, Ltd. 2201 Interest of corporation controlled by you
Guo Guangchang 2201 Interest of corporation controlled by you
Fosun Holdings Limited 2201 Interest of corporation controlled by you
Fosun International Holdings Ltd. 2201 Interest of corporation controlled by you
Fosun International Limited 2201 Interest of corporation controlled by you
Miyt Holdings Limited 2101 Beneficial owner

YSB Headlines

No Headlines